Solvay Sells Drugs Unit to Abbott for €4.5 Billion

11.12.2009 - Belgian drugs, chemicals and plastics maker Solvay said it would sell its drugs unit to U.S. partner Abbott Laboratories for €4.5 billion ($6.6 billion) in cash and reinvest in...